Walleye Trading’s Akero Therapeutics AKRO Stock Holding History

Walleye Trading’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,700	Closed	-$80.7K	–	4274
2025 Q3	$80.7K	Buy	+1,700	New	+$82.3K	﹤0.01%	3810
2024 Q2	–	Sell	-1,500	Closed	-$37.9K	–	4209
2024 Q1	$37.9K	Sell	1,500 -4,300	-74%	-$103K	﹤0.01%	4087
2023 Q4	$135K	Sell	5,800 -26,200	-82%	-$517K	﹤0.01%	4005
2023 Q3	$1.62M	Sell	32,000 -29,700	-48%	-$1.38M	﹤0.01%	1952
2023 Q2	$2.88M	Buy	61,700 +54,700	+781%	+$2.51M	0.01%	1381
2023 Q1	$268K	Buy	7,000 +5,300	+312%	+$236K	﹤0.01%	3303
2022 Q4	$93.2K	Sell	1,700 -67,700	-98%	-$2.9M	﹤0.01%	4010
2022 Q3	$2.36M	Buy	+69,400	New	+$1.06M	0.01%	1569

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's AKRO Position: Q1 2024 in Review

Walleye Trading sold out of Akero Therapeutics (AKRO) in Q1 2024, closing a stake of 116,054 shares — an estimated $2.79M sold.

Walleye Trading first reported a position in AKRO in Q3 2022 and held it in 6 quarters. The position peaked at $5.85M in Q3 2023. 173 funds tracked by Wall St. Rank hold AKRO as of Q1 2024.

Walleye Trading reported no remaining Akero Therapeutics position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 116,054 Akero Therapeutics shares in Q1 2024, an estimated $2.79M.
Walleye Trading first reported a position in Akero Therapeutics in Q3 2022 and held it in 6 quarters.
Walleye Trading's Akero Therapeutics position peaked at $5.85M in Q3 2023.
173 funds tracked by Wall St. Rank held Akero Therapeutics as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.